Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q95990105
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010745.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q95990105
|
024
|
|
|
‡a
0000-0002-3644-8208
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q95990105
|
100
|
0 |
|
‡a
Anna K Jäger
‡c
researcher
‡9
en
|
375
|
|
|
‡a
2
‡2
iso5218
|
400
|
0 |
|
‡a
Anna K Jäger
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's 6-O-Methylkrigeine, a new Amaryllidaceae alkaloid fromNerine huttoniaeSchönland
|
670
|
|
|
‡a
Author's Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Corydalis cava Schweigg. & Kort
|
670
|
|
|
‡a
Author's Activity of medicinal plants from Ghana against the parasitic gut protist Blastocystis
|
670
|
|
|
‡a
Author's Activity of traditional South African sedative and potentially CNS-acting plants in the GABA-benzodiazepine receptor assay
|
670
|
|
|
‡a
Author's Advancing HPLC-PDA-HRMS-SPE-NMR Analysis of Coumarins in Coleonema album by Use of Orthogonal Reversed-Phase C18 and Pentafluorophenyl Separations.
|
670
|
|
|
‡a
Author's Alkaloids from Boophane disticha with affinity to the serotonin transporter in rat brain
|
670
|
|
|
‡a
Author's Amides from Piper capense with CNS activity - a preliminary SAR analysis
|
670
|
|
|
‡a
Author's Antacid activity of Laportea aestuans (L.) Chew
|
670
|
|
|
‡a
Author's Anti-diabetic xanthones from the bark of Garcinia xanthochymus
|
670
|
|
|
‡a
Author's Anti-histamine effect of Rubia tibetica, used to treat anaphylaxis caused by tick bites in the Pamir Mountains, Afghanistan
|
670
|
|
|
‡a
Author's Anticonvulsant effects ofSearsia dentata
|
670
|
|
|
‡a
Author's Anticonvulsant effects ofSearsia dentata(Anacardiaceae) leaf extract in rats
|
670
|
|
|
‡a
Author's Antiinflammatory and neurological activity of pyrithione and related sulfur-containing pyridine N-oxides from Persian shallot (Allium stipitatum).
|
670
|
|
|
‡a
Author's Antioxidant activity and phenylpropanoids of Phlomis lychnitis L.: a traditional herbal tea.
|
670
|
|
|
‡a
Author's Antiplasmodial and GABA(A)-benzodiazepine receptor binding activities of five plants used in traditional medicine in Mali, West Africa
|
670
|
|
|
‡a
Author's Biflavones from Rhus species with affinity for the GABA
|
670
|
|
|
‡a
Author's Biflavones from Rhus species with affinity for the GABA(A)/benzodiazepine receptor
|
670
|
|
|
‡a
Author's Biological activity and LC-MS/MS profiling of extracts from the Australian medicinal plant Acacia ligulata
|
670
|
|
|
‡a
Author's Biological activity and LC-MS/MS profiling of extracts from the Australian medicinal plant Acacia ligulata (Fabaceae).
|
670
|
|
|
‡a
Author's Can phylogeny predict chemical diversity and potential medicinal activity of plants? A case study of Amaryllidaceae
|
670
|
|
|
‡a
Author's Comparative ethnobotany of the Wakhi agropastoralist and the Kyrgyz nomads of Afghanistan
|
670
|
|
|
‡a
Author's Corrigendum to ‘Hyaluronidase, phospholipase A2 and protease inhibitory activity of plants used in traditional treatment of snakebite-induced tissue necrosis in Mali, DR Congo and South Africa’
|
670
|
|
|
‡a
Author's Cross-cultural comparison of medicinal floras used against snakebites.
|
670
|
|
|
‡a
Author's Determination of the Wound Healing Potentials of Medicinal Plants Historically Used in Ghana
|
670
|
|
|
‡a
Author's Dual High-Resolution α-Glucosidase and Radical Scavenging Profiling Combined with HPLC-HRMS-SPE-NMR for Identification of Minor and Major Constituents Directly from the Crude Extract of Pueraria lobata
|
670
|
|
|
‡a
Author's Edible seaweed as future functional food: Identification of α-glucosidase inhibitors by combined use of high-resolution α-glucosidase inhibition profiling and HPLC-HRMS-SPE-NMR.
|
670
|
|
|
‡a
Author's Effects of South African traditional medicine in animal models for depression
|
670
|
|
|
‡a
Author's Erratum: Unsafe abortion in rural Tanzania - the use of traditional medicine from a patient and a provider perspective.
|
670
|
|
|
‡a
Author's Evaluation of the antidiabetic potential of Psidium guajava L. (Myrtaceae) using assays for α-glucosidase, α-amylase, muscle glucose uptake, liver glucose production and triglyceride accumulation in adipocytes
|
670
|
|
|
‡a
Author's Exploring Pharmacological Mechanisms of Lavender (Lavandula angustifolia) Essential Oil on Central Nervous System Targets
|
670
|
|
|
‡a
Author's Facilitated Visual Interpretation of Scores in Principal Component Analysis by Bioactivity-Labeling of 1H-NMR Spectra-Metabolomics Investigation and Identification of a New α-Glucosidase Inhibitor in Radix Astragali.
|
670
|
|
|
‡a
Author's Flavonoids and the CNS
|
670
|
|
|
‡a
Author's High-resolution bacterial growth inhibition profiling combined with HPLC-HRMS-SPE-NMR for identification of antibacterial constituents in Chinese plants used to treat snakebites.
|
670
|
|
|
‡a
Author's High-resolution hyaluronidase inhibition profiling combined with HPLC-HRMS-SPE-NMR for identification of anti-necrosis constituents in Chinese plants used to treat snakebite.
|
670
|
|
|
‡a
Author's High-Resolution Inhibition Profiling Combined with HPLC-HRMS-SPE-NMR for Identification of PTP1B Inhibitors from Vietnamese Plants.
|
670
|
|
|
‡a
Author's High-resolution PTP1B inhibition profiling combined with high-performance liquid chromatography-high-resolution mass spectrometry-solid-phase extraction-nuclear magnetic resonance spectroscopy: Proof-of-concept and antidiabetic constituents in crude
|
670
|
|
|
‡a
Author's High-Resolution α-Amylase Assay Combined with High-Performance Liquid Chromatography–Solid-Phase Extraction–Nuclear Magnetic Resonance Spectroscopy for Expedited Identification of α-Amylase Inhibitors: Proof of Concept and α-Amylase Inhibitor
|
670
|
|
|
‡a
Author's Hyaluronidase, phospholipase A2 and protease inhibitory activity of plants used in traditional treatment of snakebite-induced tissue necrosis in Mali, DR Congo and South Africa
|
670
|
|
|
‡a
Author's Hyperforin Accumulates in the Translucent Glands of Hypericum perforatum.
|
670
|
|
|
‡a
Author's Identification and characterization of a new antifungal peptide in fermented milk product containing bioprotective Lactobacillus cultures
|
670
|
|
|
‡a
Author's Identification of common horsetail (Equisetum arvense L.; Equisetaceae) using Thin Layer Chromatography versus DNA barcoding
|
670
|
|
|
‡a
Author's Inhibition of [3H]citalopram binding to the rat brain serotonin transporter by Amaryllidaceae alkaloids
|
670
|
|
|
‡a
Author's Investigation of antidiabetic potential of Phyllanthus niruri L. using assays for α-glucosidase, muscle glucose transport, liver glucose production, and adipogenesis
|
670
|
|
|
‡a
Author's Investigation of skin permeation, ex vivo inhibition of venom-induced tissue destruction, and wound healing of African plants used against snakebites
|
670
|
|
|
‡a
Author's Isolation of the MAO-inhibitor naringenin from Mentha aquatica L.
|
670
|
|
|
‡a
Author's MAO-A inhibitory activity of quercetin from Calluna vulgaris (L.) Hull
|
670
|
|
|
‡a
Author's Mechanistic study of the inhibitory activity of Geum urbanum extract against α-Synuclein fibrillation.
|
670
|
|
|
‡a
Author's Medicinal plants used as excipients in the history in Ghanaian herbal medicine
|
670
|
|
|
‡a
Author's Monosaccharide analysis of succulent leaf tissue in Aloe
|
670
|
|
|
‡a
Author's Neuroprotective and neurochemical properties of mint extracts
|
670
|
|
|
‡a
Author's Neuroprotective and neurological properties of Melissa officinalis.
|
670
|
|
|
‡a
Author's Pharmacological properties of Anagallis arvensis L.
|
670
|
|
|
‡a
Author's Pharmacological properties of Anagallis arvensis L. ( "scarlet pimpernel" ) and Anagallis foemina Mill. ( "blue pimpernel" ) traditionally used as wound healing remedies in Navarra (Spain).
|
670
|
|
|
‡a
Author's Pharmacological screening of Malian medicinal plants used against epilepsy and convulsions
|
670
|
|
|
‡a
Author's Phylogenetic selection of Narcissus species for drug discovery
|
670
|
|
|
‡a
Author's Potential of Sorbus berry extracts for management of type 2 diabetes: Metabolomics investigation of 1H NMR spectra, α-amylase and α-glucosidase inhibitory activities, and in vivo anti-hyperglycaemic activity of S. norvegica
|
670
|
|
|
‡a
Author's Review of antidiabetic fruits, vegetables, beverages, oils and spices commonly consumed in the diet
|
670
|
|
|
‡a
Author's Review on plants with CNS-effects used in traditional South African medicine against mental diseases
|
670
|
|
|
‡a
Author's Screening for potential α-glucosidase and α-amylase inhibitory constituents from selected Vietnamese plants used to treat type 2 diabetes
|
670
|
|
|
‡a
Author's Screening of indigenous plants from South Africa for affinity to the serotonin reuptake transport protein
|
670
|
|
|
‡a
Author's Screening of plants used in Danish folk medicine to treat depression and anxiety for affinity to the serotonin transporter and inhibition of MAO-A.
|
670
|
|
|
‡a
Author's Screening of plants used in Danish folk medicine to treat epilepsy and convulsions
|
670
|
|
|
‡a
Author's Screening of plants used in Danish folk medicine to treat memory dysfunction for acetylcholinesterase inhibitory activity
|
670
|
|
|
‡a
Author's Screening of plants used in southern Africa for epilepsy and convulsions in the GABAA-benzodiazepine receptor assay
|
670
|
|
|
‡a
Author's Screening of plants used in the European traditional medicine to treat memory disorders for acetylcholinesterase inhibitory activity and anti amyloidogenic activity.
|
670
|
|
|
‡a
Author's Targeted Natural Product Isolation Guided by HPLC–SPE–NMR: Constituents ofHubertiaSpecies
|
670
|
|
|
‡a
Author's The effect of extracts of Searsia species on epileptiform activity in slices of the mouse cerebral cortex
|
670
|
|
|
‡a
Author's The first phylogenetic hypothesis for the southern African endemic genus Tulbaghia (Amaryllidaceae, Allioideae) based on plastid and nuclear DNA sequences
|
670
|
|
|
‡a
Author's The first phylogenetic hypothesis for the southern African endemic genusTulbaghia(Amaryllidaceae, Allioideae) based on plastid and nuclear DNA sequences
|
670
|
|
|
‡a
Author's The Inhibitory Effect of Natural Products on Protein Fibrillation May Be Caused by Degradation Products--A Study Using Aloin and Insulin
|
670
|
|
|
‡a
Author's The polyacetylene falcarindiol with COX-1 activity isolated from Aegopodium podagraria L.
|
670
|
|
|
‡a
Author's Traditional medicine among people of Pakistani descent in the capital region of Copenhagen.
|
670
|
|
|
‡a
Author's Triple aldose reductase/α-glucosidase/radical scavenging high-resolution profiling combined with high-performance liquid chromatography–high-resolution mass spectrometry–solid-phase extraction–nuclear magnetic resonance spectroscopy for identi
|
670
|
|
|
‡a
Author's Ubiquitous plant compounds disturb cell-based assays
|
670
|
|
|
‡a
Author's Unsafe abortion in rural Tanzania - the use of traditional medicine from a patient and a provider perspective
|
670
|
|
|
‡a
Author's Using a phylogenetic approach to selection of target plants in drug discovery of acetylcholinesterase inhibiting alkaloids in Amaryllidaceae tribe Galantheae
|
670
|
|
|
‡a
Author's Uterine contraction induced by Tanzanian plants used to induce abortion.
|
670
|
|
|
‡a
Author's Xanthones from the twigs of Garcinia oblongifolia and their antidiabetic activity
|
909
|
|
|
‡a
(orcid) 0000000236448208
‡9
1
|
919
|
|
|
‡a
flavonoidsandthecns
‡A
Flavonoids and the CNS
‡9
1
|
919
|
|
|
‡a
facilitatedvisualinterpretationofscoresinprincipalcomponentanalysisbybioactivitylabelingof1hnmrspectrametabolomicsinvestigationandidentificationofanewαglucosidaseinhibitorinradixastragali
‡A
Facilitated Visual Interpretation of Scores in Principal Component Analysis by Bioactivity-Labeling of 1H-NMR Spectra-Metabolomics Investigation and Identification of a New α-Glucosidase Inhibitor in Radix Astragali.
‡9
1
|
919
|
|
|
‡a
exploringpharmacologicalmechanismsoflavenderlavandulaangustifoliaessentialoiloncentralnervoussystemtargets
‡A
Exploring Pharmacological Mechanisms of Lavender (Lavandula angustifolia) Essential Oil on Central Nervous System Targets
‡9
1
|
919
|
|
|
‡a
evaluationoftheantidiabeticpotentialofpsidiumguajava50myrtaceaeusingassaysforαglucosidaseαamylasemuscleglucoseuptakeliverglucoseproductionandtriglycerideaccumulationinadipocytes
‡A
Evaluation of the antidiabetic potential of Psidium guajava L. (Myrtaceae) using assays for α-glucosidase, α-amylase, muscle glucose uptake, liver glucose production and triglyceride accumulation in adipocytes
‡9
1
|
919
|
|
|
‡a
erratumunsafeabortioninruraltanzaniatheuseoftraditionalmedicinefromapatientandaproviderperspective
‡A
Erratum: Unsafe abortion in rural Tanzania - the use of traditional medicine from a patient and a provider perspective.
‡9
1
|
919
|
|
|
‡a
effectsofsouthafricantraditionalmedicineinanimalmodelsfordepression
‡A
Effects of South African traditional medicine in animal models for depression
‡9
1
|
919
|
|
|
‡a
edibleseaweedasfuturefunctionalfoodidentificationofαglucosidaseinhibitorsbycombineduseofhighresolutionαglucosidaseinhibitionprofilingandhplchrmsspenmr
‡A
Edible seaweed as future functional food: Identification of α-glucosidase inhibitors by combined use of high-resolution α-glucosidase inhibition profiling and HPLC-HRMS-SPE-NMR.
‡9
1
|
919
|
|
|
‡a
dualhighresolutionαglucosidaseandradicalscavengingprofilingcombinedwithhplchrmsspenmrforidentificationofminorandmajorconstituentsdirectlyfromthecrudeextractofpuerarialobata
‡A
Dual High-Resolution α-Glucosidase and Radical Scavenging Profiling Combined with HPLC-HRMS-SPE-NMR for Identification of Minor and Major Constituents Directly from the Crude Extract of Pueraria lobata
‡9
1
|
919
|
|
|
‡a
determinationofthewoundhealingpotentialsofmedicinalplantshistoricallyusedinghana
‡A
Determination of the Wound Healing Potentials of Medicinal Plants Historically Used in Ghana
‡9
1
|
919
|
|
|
‡a
6omethylkrigeineanewamaryllidaceaealkaloidfromnerinehuttoniaeschonland
‡A
6-O-Methylkrigeine, a new Amaryllidaceae alkaloid fromNerine huttoniaeSchönland
‡9
1
|
919
|
|
|
‡a
acetylcholinesteraseandbutyrylcholinesteraseinhibitorycompoundsfromcorydaliscavaschweiggandkort
‡A
Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Corydalis cava Schweigg. & Kort
‡9
1
|
919
|
|
|
‡a
activityofmedicinalplantsfromghanaagainsttheparasiticgutprotistblastocystis
‡A
Activity of medicinal plants from Ghana against the parasitic gut protist Blastocystis
‡9
1
|
919
|
|
|
‡a
activityoftraditionalsouthafricansedativeandpotentiallycnsactingplantsinthegababenzodiazepinereceptorassay
‡A
Activity of traditional South African sedative and potentially CNS-acting plants in the GABA-benzodiazepine receptor assay
‡9
1
|
919
|
|
|
‡a
advancinghplcpdahrmsspenmranalysisofcoumarinsincoleonemaalbumbyuseoforthogonalreversedphasec18andpentafluorophenylseparations
‡A
Advancing HPLC-PDA-HRMS-SPE-NMR Analysis of Coumarins in Coleonema album by Use of Orthogonal Reversed-Phase C18 and Pentafluorophenyl Separations.
‡9
1
|
919
|
|
|
‡a
alkaloidsfromboophanedistichawithaffinitytotheserotonintransporterinratbrain
‡A
Alkaloids from Boophane disticha with affinity to the serotonin transporter in rat brain
‡9
1
|
919
|
|
|
‡a
amidesfrompipercapensewithcnsactivityapreliminarysaranalysis
‡A
Amides from Piper capense with CNS activity - a preliminary SAR analysis
‡9
1
|
919
|
|
|
‡a
antacidactivityoflaporteaaestuans50chew
‡A
Antacid activity of Laportea aestuans (L.) Chew
‡9
1
|
919
|
|
|
‡a
antidiabeticxanthonesfromthebarkofgarciniaxanthochymus
‡A
Anti-diabetic xanthones from the bark of Garcinia xanthochymus
‡9
1
|
919
|
|
|
‡a
antihistamineeffectofrubiatibeticausedtotreatanaphylaxiscausedbytickbitesinthepamirmountainsafghanistan
‡A
Anti-histamine effect of Rubia tibetica, used to treat anaphylaxis caused by tick bites in the Pamir Mountains, Afghanistan
‡9
1
|
919
|
|
|
‡a
anticonvulsanteffectsofsearsiadentata
‡A
Anticonvulsant effects ofSearsia dentata
‡9
1
|
919
|
|
|
‡a
anticonvulsanteffectsofsearsiadentataanacardiaceaeleafextractinrats
‡A
Anticonvulsant effects ofSearsia dentata(Anacardiaceae) leaf extract in rats
‡9
1
|
919
|
|
|
‡a
antiinflammatoryandneurologicalactivityofpyrithioneandrelatedsulfurcontainingpyridinenoxidesfrompersianshallotalliumstipitatum
‡A
Antiinflammatory and neurological activity of pyrithione and related sulfur-containing pyridine N-oxides from Persian shallot (Allium stipitatum).
‡9
1
|
919
|
|
|
‡a
antioxidantactivityandphenylpropanoidsofphlomislychnitis50atraditionalherbaltea
‡A
Antioxidant activity and phenylpropanoids of Phlomis lychnitis L.: a traditional herbal tea.
‡9
1
|
919
|
|
|
‡a
antiplasmodialandgabaabenzodiazepinereceptorbindingactivitiesof5plantsusedintraditionalmedicineinmaliwestafrica
‡A
Antiplasmodial and GABA(A)-benzodiazepine receptor binding activities of five plants used in traditional medicine in Mali, West Africa
‡9
1
|
919
|
|
|
‡a
biflavonesfromrhusspecieswithaffinityforthegaba
‡A
Biflavones from Rhus species with affinity for the GABA
‡9
1
|
919
|
|
|
‡a
biflavonesfromrhusspecieswithaffinityforthegabaabenzodiazepinereceptor
‡A
Biflavones from Rhus species with affinity for the GABA(A)/benzodiazepine receptor
‡9
1
|
919
|
|
|
‡a
biologicalactivityandlcmsmsprofilingofextractsfromtheaustralianmedicinalplantacacialigulata
‡A
Biological activity and LC-MS/MS profiling of extracts from the Australian medicinal plant Acacia ligulata
‡9
1
|
919
|
|
|
‡a
biologicalactivityandlcmsmsprofilingofextractsfromtheaustralianmedicinalplantacacialigulatafabaceae
‡A
Biological activity and LC-MS/MS profiling of extracts from the Australian medicinal plant Acacia ligulata (Fabaceae).
‡9
1
|
919
|
|
|
‡a
canphylogenypredictchemicaldiversityandpotentialmedicinalactivityofplantsacasestudyofamaryllidaceae
‡A
Can phylogeny predict chemical diversity and potential medicinal activity of plants? A case study of Amaryllidaceae
‡9
1
|
919
|
|
|
‡a
comparativeethnobotanyofthewakhiagropastoralistandthekyrgyznomadsofafghanistan
‡A
Comparative ethnobotany of the Wakhi agropastoralist and the Kyrgyz nomads of Afghanistan
‡9
1
|
919
|
|
|
‡a
corrigendumtohyaluronidasephospholipasea2andproteaseinhibitoryactivityofplantsusedintraditionaltreatmentofsnakebiteinducedtissuenecrosisinmalidrcongoandsouthafrica
‡A
Corrigendum to ‘Hyaluronidase, phospholipase A2 and protease inhibitory activity of plants used in traditional treatment of snakebite-induced tissue necrosis in Mali, DR Congo and South Africa’
‡9
1
|
919
|
|
|
‡a
xanthonesfromthetwigsofgarciniaoblongifoliaandtheirantidiabeticactivity
‡A
Xanthones from the twigs of Garcinia oblongifolia and their antidiabetic activity
‡9
1
|
919
|
|
|
‡a
uterinecontractioninducedbytanzanianplantsusedtoinduceabortion
‡A
Uterine contraction induced by Tanzanian plants used to induce abortion.
‡9
1
|
919
|
|
|
‡a
usingaphylogeneticapproachtoselectionoftargetplantsindrugdiscoveryofacetylcholinesteraseinhibitingalkaloidsinamaryllidaceaetribegalantheae
‡A
Using a phylogenetic approach to selection of target plants in drug discovery of acetylcholinesterase inhibiting alkaloids in Amaryllidaceae tribe Galantheae
‡9
1
|
919
|
|
|
‡a
unsafeabortioninruraltanzaniatheuseoftraditionalmedicinefromapatientandaproviderperspective
‡A
Unsafe abortion in rural Tanzania - the use of traditional medicine from a patient and a provider perspective
‡9
1
|
919
|
|
|
‡a
ubiquitousplantcompoundsdisturbcellbasedassays
‡A
Ubiquitous plant compounds disturb cell-based assays
‡9
1
|
919
|
|
|
‡a
triplealdosereductaseαglucosidaseradicalscavenginghighresolutionprofilingcombinedwithhighperformanceliquidchromatographyhighresolutionmassspectrometrysolidphaseextractionnuclearmagneticresonancespectroscopyforidenti
‡A
Triple aldose reductase/α-glucosidase/radical scavenging high-resolution profiling combined with high-performance liquid chromatography–high-resolution mass spectrometry–solid-phase extraction–nuclear magnetic resonance spectroscopy for identi
‡9
1
|
919
|
|
|
‡a
traditionalmedicineamongpeopleofpakistanidescentinthecapitalregionofcopenhagen
‡A
Traditional medicine among people of Pakistani descent in the capital region of Copenhagen.
‡9
1
|
919
|
|
|
‡a
polyacetylenefalcarindiolwithcox1activityisolatedfromaegopodiumpodagraria50
‡A
The polyacetylene falcarindiol with COX-1 activity isolated from Aegopodium podagraria L.
‡9
1
|
919
|
|
|
‡a
inhibitoryeffectofnaturalproductsonproteinfibrillationmaybecausedbydegradationproductsastudyusingaloinandinsulin
‡A
The Inhibitory Effect of Natural Products on Protein Fibrillation May Be Caused by Degradation Products--A Study Using Aloin and Insulin
‡9
1
|
919
|
|
|
‡a
1phylogenetichypothesisforthesouthernafricanendemicgenustulbaghiaamaryllidaceaeallioideaebasedonplastidandnucleardnasequences
‡A
The first phylogenetic hypothesis for the southern African endemic genusTulbaghia(Amaryllidaceae, Allioideae) based on plastid and nuclear DNA sequences
‡9
2
|
919
|
|
|
‡a
effectofextractsofsearsiaspeciesonepileptiformactivityinslicesofthemousecerebralcortex
‡A
The effect of extracts of Searsia species on epileptiform activity in slices of the mouse cerebral cortex
‡9
1
|
919
|
|
|
‡a
targetednaturalproductisolationguidedbyhplcspenmrconstituentsofhubertiaspecies
‡A
Targeted Natural Product Isolation Guided by HPLC–SPE–NMR: Constituents ofHubertiaSpecies
‡9
1
|
919
|
|
|
‡a
screeningofplantsusedintheeuropeantraditionalmedicinetotreatmemorydisordersforacetylcholinesteraseinhibitoryactivityandantiamyloidogenicactivity
‡A
Screening of plants used in the European traditional medicine to treat memory disorders for acetylcholinesterase inhibitory activity and anti amyloidogenic activity.
‡9
1
|
919
|
|
|
‡a
screeningofplantsusedinsouthernafricaforepilepsyandconvulsionsinthegabaabenzodiazepinereceptorassay
‡A
Screening of plants used in southern Africa for epilepsy and convulsions in the GABAA-benzodiazepine receptor assay
‡9
1
|
919
|
|
|
‡a
screeningofplantsusedindanishfolkmedicinetotreatmemorydysfunctionforacetylcholinesteraseinhibitoryactivity
‡A
Screening of plants used in Danish folk medicine to treat memory dysfunction for acetylcholinesterase inhibitory activity
‡9
1
|
919
|
|
|
‡a
screeningofplantsusedindanishfolkmedicinetotreatepilepsyandconvulsions
‡A
Screening of plants used in Danish folk medicine to treat epilepsy and convulsions
‡9
1
|
919
|
|
|
‡a
screeningofplantsusedindanishfolkmedicinetotreatdepressionandanxietyforaffinitytotheserotonintransporterandinhibitionofmaoa
‡A
Screening of plants used in Danish folk medicine to treat depression and anxiety for affinity to the serotonin transporter and inhibition of MAO-A.
‡9
1
|
919
|
|
|
‡a
crossculturalcomparisonofmedicinalflorasusedagainstsnakebites
‡A
Cross-cultural comparison of medicinal floras used against snakebites.
‡9
1
|
919
|
|
|
‡a
screeningofindigenousplantsfromsouthafricaforaffinitytotheserotoninreuptaketransportprotein
‡A
Screening of indigenous plants from South Africa for affinity to the serotonin reuptake transport protein
‡9
1
|
919
|
|
|
‡a
screeningforpotentialαglucosidaseandαamylaseinhibitoryconstituentsfromselectedvietnameseplantsusedtotreattype2diabetes
‡A
Screening for potential α-glucosidase and α-amylase inhibitory constituents from selected Vietnamese plants used to treat type 2 diabetes
‡9
1
|
919
|
|
|
‡a
reviewonplantswithcnseffectsusedintraditionalsouthafricanmedicineagainstmentaldiseases
‡A
Review on plants with CNS-effects used in traditional South African medicine against mental diseases
‡9
1
|
919
|
|
|
‡a
reviewofantidiabeticfruitsvegetablesbeveragesoilsandspicescommonlyconsumedinthediet
‡A
Review of antidiabetic fruits, vegetables, beverages, oils and spices commonly consumed in the diet
‡9
1
|
919
|
|
|
‡a
potentialofsorbusberryextractsformanagementoftype2diabetesmetabolomicsinvestigationof1hnmrspectraαamylaseandαglucosidaseinhibitoryactivitiesandinvivoantihyperglycaemicactivityofsnorvegica
‡A
Potential of Sorbus berry extracts for management of type 2 diabetes: Metabolomics investigation of 1H NMR spectra, α-amylase and α-glucosidase inhibitory activities, and in vivo anti-hyperglycaemic activity of S. norvegica
‡9
1
|
919
|
|
|
‡a
phylogeneticselectionofnarcissusspeciesfordrugdiscovery
‡A
Phylogenetic selection of Narcissus species for drug discovery
‡9
1
|
919
|
|
|
‡a
pharmacologicalscreeningofmalianmedicinalplantsusedagainstepilepsyandconvulsions
‡A
Pharmacological screening of Malian medicinal plants used against epilepsy and convulsions
‡9
1
|
919
|
|
|
‡a
pharmacologicalpropertiesofanagallisarvensis50scarletpimpernelandanagallisfoeminamillbluepimperneltraditionallyusedaswoundhealingremediesinnavarraspain
‡A
Pharmacological properties of Anagallis arvensis L. ( "scarlet pimpernel" ) and Anagallis foemina Mill. ( "blue pimpernel" ) traditionally used as wound healing remedies in Navarra (Spain).
‡9
1
|
919
|
|
|
‡a
pharmacologicalpropertiesofanagallisarvensis50
‡A
Pharmacological properties of Anagallis arvensis L.
‡9
1
|
919
|
|
|
‡a
neuroprotectiveandneurologicalpropertiesofmelissaofficinalis
‡A
Neuroprotective and neurological properties of Melissa officinalis.
‡9
1
|
919
|
|
|
‡a
neuroprotectiveandneurochemicalpropertiesofmintextracts
‡A
Neuroprotective and neurochemical properties of mint extracts
‡9
1
|
919
|
|
|
‡a
monosaccharideanalysisofsucculentleaftissueinaloe
‡A
Monosaccharide analysis of succulent leaf tissue in Aloe
‡9
1
|
919
|
|
|
‡a
medicinalplantsusedasexcipientsinthehistoryinghanaianherbalmedicine
‡A
Medicinal plants used as excipients in the history in Ghanaian herbal medicine
‡9
1
|
919
|
|
|
‡a
mechanisticstudyoftheinhibitoryactivityofgeumurbanumextractagainstαsynucleinfibrillation
‡A
Mechanistic study of the inhibitory activity of Geum urbanum extract against α-Synuclein fibrillation.
‡9
1
|
919
|
|
|
‡a
maoainhibitoryactivityofquercetinfromcallunavulgaris50hull
‡A
MAO-A inhibitory activity of quercetin from Calluna vulgaris (L.) Hull
‡9
1
|
919
|
|
|
‡a
isolationofthemaoinhibitornaringeninfrommenthaaquatica50
‡A
Isolation of the MAO-inhibitor naringenin from Mentha aquatica L.
‡9
1
|
919
|
|
|
‡a
investigationofskinpermeationexvivoinhibitionofvenominducedtissuedestructionandwoundhealingofafricanplantsusedagainstsnakebites
‡A
Investigation of skin permeation, ex vivo inhibition of venom-induced tissue destruction, and wound healing of African plants used against snakebites
‡9
1
|
919
|
|
|
‡a
investigationofantidiabeticpotentialofphyllanthusniruri50usingassaysforαglucosidasemuscleglucosetransportliverglucoseproductionandadipogenesis
‡A
Investigation of antidiabetic potential of Phyllanthus niruri L. using assays for α-glucosidase, muscle glucose transport, liver glucose production, and adipogenesis
‡9
1
|
919
|
|
|
‡a
inhibitionofcitaloprambindingtotheratbrainserotonintransporterbyamaryllidaceaealkaloids
‡A
Inhibition of [3H]citalopram binding to the rat brain serotonin transporter by Amaryllidaceae alkaloids
‡9
1
|
919
|
|
|
‡a
identificationofcommonhorsetailequisetumarvense50equisetaceaeusingthinlayerchromatographyversusdnabarcoding
‡A
Identification of common horsetail (Equisetum arvense L.; Equisetaceae) using Thin Layer Chromatography versus DNA barcoding
‡9
1
|
919
|
|
|
‡a
identificationandcharacterizationofanewantifungalpeptideinfermentedmilkproductcontainingbioprotectivelactobacilluscultures
‡A
Identification and characterization of a new antifungal peptide in fermented milk product containing bioprotective Lactobacillus cultures
‡9
1
|
919
|
|
|
‡a
hyperforinaccumulatesinthetranslucentglandsofhypericumperforatum
‡A
Hyperforin Accumulates in the Translucent Glands of Hypericum perforatum.
‡9
1
|
919
|
|
|
‡a
hyaluronidasephospholipasea2andproteaseinhibitoryactivityofplantsusedintraditionaltreatmentofsnakebiteinducedtissuenecrosisinmalidrcongoandsouthafrica
‡A
Hyaluronidase, phospholipase A2 and protease inhibitory activity of plants used in traditional treatment of snakebite-induced tissue necrosis in Mali, DR Congo and South Africa
‡9
1
|
919
|
|
|
‡a
highresolutionαamylaseassaycombinedwithhighperformanceliquidchromatographysolidphaseextractionnuclearmagneticresonancespectroscopyforexpeditedidentificationofαamylaseinhibitorsproofofconceptandαamylaseinhibitor
‡A
High-Resolution α-Amylase Assay Combined with High-Performance Liquid Chromatography–Solid-Phase Extraction–Nuclear Magnetic Resonance Spectroscopy for Expedited Identification of α-Amylase Inhibitors: Proof of Concept and α-Amylase Inhibitor
‡9
1
|
919
|
|
|
‡a
highresolutionptp1binhibitionprofilingcombinedwithhighperformanceliquidchromatographyhighresolutionmassspectrometrysolidphaseextractionnuclearmagneticresonancespectroscopyproofofconceptandantidiabeticconstituentsincrude
‡A
High-resolution PTP1B inhibition profiling combined with high-performance liquid chromatography-high-resolution mass spectrometry-solid-phase extraction-nuclear magnetic resonance spectroscopy: Proof-of-concept and antidiabetic constituents in crude
‡9
1
|
919
|
|
|
‡a
highresolutioninhibitionprofilingcombinedwithhplchrmsspenmrforidentificationofptp1binhibitorsfromvietnameseplants
‡A
High-Resolution Inhibition Profiling Combined with HPLC-HRMS-SPE-NMR for Identification of PTP1B Inhibitors from Vietnamese Plants.
‡9
1
|
919
|
|
|
‡a
highresolutionhyaluronidaseinhibitionprofilingcombinedwithhplchrmsspenmrforidentificationofantinecrosisconstituentsinchineseplantsusedtotreatsnakebite
‡A
High-resolution hyaluronidase inhibition profiling combined with HPLC-HRMS-SPE-NMR for identification of anti-necrosis constituents in Chinese plants used to treat snakebite.
‡9
1
|
919
|
|
|
‡a
highresolutionbacterialgrowthinhibitionprofilingcombinedwithhplchrmsspenmrforidentificationofantibacterialconstituentsinchineseplantsusedtotreatsnakebites
‡A
High-resolution bacterial growth inhibition profiling combined with HPLC-HRMS-SPE-NMR for identification of antibacterial constituents in Chinese plants used to treat snakebites.
‡9
1
|
946
|
|
|
‡a
a
‡9
1
|
996
|
|
|
‡2
NTA|071800352
|
996
|
|
|
‡2
ISNI|0000000389869417
|
996
|
|
|
‡2
SUDOC|258476613
|
996
|
|
|
‡2
LC|n 2021045901
|
996
|
|
|
‡2
LC|no2004090325
|
996
|
|
|
‡2
ISNI|0000000392708139
|
996
|
|
|
‡2
SUDOC|14967032X
|
996
|
|
|
‡2
ISNI|0000000398172929
|
996
|
|
|
‡2
NTA|068412886
|
996
|
|
|
‡2
DNB|1043007717
|
996
|
|
|
‡2
DNB|117051861
|
996
|
|
|
‡2
DNB|1147792712
|
996
|
|
|
‡2
DNB|1081375892
|
996
|
|
|
‡2
SUDOC|086092154
|
996
|
|
|
‡2
ISNI|0000000395525813
|
996
|
|
|
‡2
NTA|175582378
|
996
|
|
|
‡2
NTA|149072260
|
996
|
|
|
‡2
NTA|073032603
|
996
|
|
|
‡2
DNB|124736505
|
996
|
|
|
‡2
BIBSYS|90922885
|
996
|
|
|
‡2
NTA|325602867
|
996
|
|
|
‡2
DNB|1161766588
|
996
|
|
|
‡2
PLWABN|9810702678305606
|
996
|
|
|
‡2
DNB|132715945
|
996
|
|
|
‡2
NTA|204437385
|
996
|
|
|
‡2
ISNI|0000000022120469
|
996
|
|
|
‡2
DNB|119008963
|
996
|
|
|
‡2
DNB|1024118169
|
996
|
|
|
‡2
NTA|40234362X
|
996
|
|
|
‡2
NII|DA14893265
|
996
|
|
|
‡2
BIBSYS|90765166
|
996
|
|
|
‡2
DNB|1327189429
|
996
|
|
|
‡2
NTA|069719799
|
996
|
|
|
‡2
LC|nr 00027411
|
996
|
|
|
‡2
ISNI|0000000021589417
|
996
|
|
|
‡2
NTA|074251511
|
996
|
|
|
‡2
NTA|134500202
|
996
|
|
|
‡2
NUKAT|n 2004083728
|
996
|
|
|
‡2
BIBSYS|90159429
|
996
|
|
|
‡2
LC|n 88109626
|
996
|
|
|
‡2
J9U|987007263489305171
|
996
|
|
|
‡2
DNB|1145426891
|
996
|
|
|
‡2
NTA|068961782
|
996
|
|
|
‡2
DNB|12414506X
|
996
|
|
|
‡2
ISNI|0000000390352781
|
996
|
|
|
‡2
NTA|070358699
|
996
|
|
|
‡2
ISNI|0000000384282780
|
996
|
|
|
‡2
ISNI|0000000396114303
|
996
|
|
|
‡2
NTA|079527493
|
996
|
|
|
‡2
PLWABN|9810619812305606
|
996
|
|
|
‡2
LC|no2021034388
|
996
|
|
|
‡2
NTA|068988036
|
996
|
|
|
‡2
ISNI|0000000395617566
|
996
|
|
|
‡2
NTA|23941313X
|
996
|
|
|
‡2
NTA|180295888
|
996
|
|
|
‡2
SUDOC|191892394
|
996
|
|
|
‡2
LC|no2012050382
|
996
|
|
|
‡2
DNB|1235773035
|
996
|
|
|
‡2
NTA|421133759
|
996
|
|
|
‡2
DNB|1150789050
|
996
|
|
|
‡2
BNF|15139576
|
996
|
|
|
‡2
ISNI|0000000389961504
|
996
|
|
|
‡2
SUDOC|166584851
|
996
|
|
|
‡2
NTA|067806244
|
996
|
|
|
‡2
SUDOC|17276338X
|
996
|
|
|
‡2
NII|DA03716100
|
996
|
|
|
‡2
ISNI|0000000051344381
|
996
|
|
|
‡2
NTA|070699240
|
996
|
|
|
‡2
ISNI|0000000390120753
|
996
|
|
|
‡2
NUKAT|n 2003024629
|
996
|
|
|
‡2
LC|no2023007279
|
996
|
|
|
‡2
LC|n 95911180
|
996
|
|
|
‡2
DNB|1033637025
|
996
|
|
|
‡2
NTA|074988794
|
996
|
|
|
‡2
NTA|072717440
|
996
|
|
|
‡2
ISNI|0000000031906308
|
996
|
|
|
‡2
BIBSYS|13066074
|
996
|
|
|
‡2
ISNI|0000000391085179
|
996
|
|
|
‡2
NKC|jo2017964668
|
996
|
|
|
‡2
NUKAT|nx2023947425
|
996
|
|
|
‡2
LC|no2009023681
|
996
|
|
|
‡2
ISNI|0000000396672719
|
996
|
|
|
‡2
DNB|1298491916
|
996
|
|
|
‡2
DNB|1052598463
|
996
|
|
|
‡2
DNB|1045013250
|
996
|
|
|
‡2
NTA|411817604
|
996
|
|
|
‡2
ISNI|0000000054032850
|
996
|
|
|
‡2
NTA|327985844
|
996
|
|
|
‡2
DNB|142842745
|
996
|
|
|
‡2
ISNI|0000000393835594
|
996
|
|
|
‡2
DNB|1053151802
|
996
|
|
|
‡2
BIBSYS|12032594
|
996
|
|
|
‡2
NTA|394163338
|
996
|
|
|
‡2
ISNI|0000000042294757
|
996
|
|
|
‡2
NTA|074743023
|
996
|
|
|
‡2
DNB|1137736224
|
996
|
|
|
‡2
NTA|215688708
|
996
|
|
|
‡2
DNB|139681825
|
996
|
|
|
‡2
ISNI|0000000044064824
|
996
|
|
|
‡2
DNB|1273295307
|
996
|
|
|
‡2
NUKAT|n 2022066021
|
996
|
|
|
‡2
ISNI|0000000398254406
|
996
|
|
|
‡2
SUDOC|158733975
|
996
|
|
|
‡2
VLACC|000046163
|
996
|
|
|
‡2
DNB|1222576228
|
996
|
|
|
‡2
NTA|390672580
|
996
|
|
|
‡2
ISNI|0000000073005583
|
996
|
|
|
‡2
ISNI|0000000062420722
|
996
|
|
|
‡2
LC|no2008000269
|
996
|
|
|
‡2
ISNI|0000000053962407
|
996
|
|
|
‡2
ISNI|0000000389283440
|
996
|
|
|
‡2
NTA|174400624
|
996
|
|
|
‡2
DNB|132847906
|
996
|
|
|
‡2
ISNI|0000000054279247
|
996
|
|
|
‡2
DNB|120641100
|
996
|
|
|
‡2
NTA|434009903
|
996
|
|
|
‡2
NTA|291117988
|
996
|
|
|
‡2
ISNI|0000000387463528
|
996
|
|
|
‡2
ISNI|0000000057146124
|
996
|
|
|
‡2
ISNI|0000000054160836
|
996
|
|
|
‡2
ISNI|0000000388116675
|
996
|
|
|
‡2
ISNI|0000000397211797
|
996
|
|
|
‡2
NTA|069968683
|
996
|
|
|
‡2
NTA|296011800
|
996
|
|
|
‡2
DNB|134415809
|
996
|
|
|
‡2
ISNI|0000000055022670
|
996
|
|
|
‡2
NTA|139404384
|
996
|
|
|
‡2
ISNI|0000000394571076
|
996
|
|
|
‡2
NTA|344692418
|
996
|
|
|
‡2
PLWABN|9811780929505606
|
996
|
|
|
‡2
BNF|14476963
|
996
|
|
|
‡2
NTA|42113173X
|
996
|
|
|
‡2
DNB|1236613023
|
996
|
|
|
‡2
DNB|1147513511
|
996
|
|
|
‡2
NTA|19758277X
|
996
|
|
|
‡2
LC|n 93097912
|
996
|
|
|
‡2
NTA|426581423
|
996
|
|
|
‡2
DNB|123809754
|
996
|
|
|
‡2
NTA|152095462
|
996
|
|
|
‡2
DNB|121517500
|
996
|
|
|
‡2
NTA|069689083
|
996
|
|
|
‡2
DE633|pe30027045
|
996
|
|
|
‡2
ISNI|0000000387277813
|
996
|
|
|
‡2
DNB|1053451059
|
996
|
|
|
‡2
ISNI|0000000397326105
|
996
|
|
|
‡2
ISNI|0000000035529618
|
996
|
|
|
‡2
DNB|1052799663
|
996
|
|
|
‡2
ISNI|0000000079036508
|
996
|
|
|
‡2
DNB|1120413664
|
996
|
|
|
‡2
ISNI|0000000391050558
|
996
|
|
|
‡2
NTA|075180081
|
996
|
|
|
‡2
NTA|418970564
|
996
|
|
|
‡2
DNB|1208675796
|
996
|
|
|
‡2
NTA|174358687
|
996
|
|
|
‡2
ISNI|0000000395926035
|
996
|
|
|
‡2
ISNI|0000000385183311
|
996
|
|
|
‡2
NTA|108240533
|
996
|
|
|
‡2
DNB|134246373
|
996
|
|
|
‡2
DNB|1228035903
|
996
|
|
|
‡2
DNB|1050382919
|
996
|
|
|
‡2
ISNI|0000000369770225
|
996
|
|
|
‡2
ISNI|0000000019638005
|
996
|
|
|
‡2
DNB|127134042
|
996
|
|
|
‡2
ISNI|0000000391533947
|
996
|
|
|
‡2
NTA|068729588
|
996
|
|
|
‡2
ISNI|0000000479776871
|
996
|
|
|
‡2
NTA|168609177
|
996
|
|
|
‡2
SUDOC|152074708
|
996
|
|
|
‡2
NTA|433974141
|
996
|
|
|
‡2
ISNI|0000000039941925
|
996
|
|
|
‡2
LC|n 2016180081
|
996
|
|
|
‡2
DE633|pe30058491
|
996
|
|
|
‡2
ISNI|000000039094914X
|
996
|
|
|
‡2
SIMACOB|276878947
|
996
|
|
|
‡2
LC|no2009030639
|
996
|
|
|
‡2
NTA|14700571X
|
996
|
|
|
‡2
DNB|1037558359
|
996
|
|
|
‡2
NTA|072389923
|
996
|
|
|
‡2
NUKAT|n 2013051115
|
996
|
|
|
‡2
BIBSYS|99031561
|
996
|
|
|
‡2
NTA|412859696
|
996
|
|
|
‡2
CAOONL|ncf10019603
|
996
|
|
|
‡2
ISNI|0000000390308756
|
996
|
|
|
‡2
ISNI|0000000391630181
|
996
|
|
|
‡2
DNB|1073173445
|
996
|
|
|
‡2
ISNI|0000000393395664
|
996
|
|
|
‡2
NTA|14737846X
|
996
|
|
|
‡2
ISNI|000000039952392X
|
996
|
|
|
‡2
ISNI|0000000467819520
|
996
|
|
|
‡2
NTA|262288125
|
996
|
|
|
‡2
NTA|304366188
|
996
|
|
|
‡2
LC|n 81011965
|
996
|
|
|
‡2
NTA|181881209
|
996
|
|
|
‡2
NTA|083283803
|
996
|
|
|
‡2
DNB|1122753179
|
996
|
|
|
‡2
NTA|21305907X
|
996
|
|
|
‡2
LC|n 82040896
|
996
|
|
|
‡2
BIBSYS|90348473
|
996
|
|
|
‡2
ISNI|0000000395095606
|
996
|
|
|
‡2
DNB|107701936X
|
996
|
|
|
‡2
DNB|117185116
|
996
|
|
|
‡2
J9U|987007345871505171
|
996
|
|
|
‡2
NTA|130319139
|
996
|
|
|
‡2
RERO|A008938180
|
996
|
|
|
‡2
ISNI|000000005845126X
|
996
|
|
|
‡2
ISNI|0000000389424960
|
996
|
|
|
‡2
ISNI|0000000021959772
|
996
|
|
|
‡2
DNB|1280827009
|
996
|
|
|
‡2
BIBSYS|90220844
|
996
|
|
|
‡2
ISNI|0000000077371222
|
996
|
|
|
‡2
ISNI|0000000395371279
|
996
|
|
|
‡2
LC|n 2008009158
|
996
|
|
|
‡2
ISNI|0000000389995368
|
996
|
|
|
‡2
NTA|069445443
|
996
|
|
|
‡2
NTA|136919715
|
996
|
|
|
‡2
DNB|119202527X
|
996
|
|
|
‡2
ISNI|0000000393423469
|
996
|
|
|
‡2
ISNI|0000000403423252
|
996
|
|
|
‡2
ISNI|0000000395374330
|
996
|
|
|
‡2
ISNI|000000005472884X
|
996
|
|
|
‡2
LC|no2007086340
|
996
|
|
|
‡2
LC|no2006115444
|
996
|
|
|
‡2
NTA|07305772X
|
996
|
|
|
‡2
NTA|168906139
|
996
|
|
|
‡2
NTA|085470325
|
996
|
|
|
‡2
ISNI|0000000392237365
|
996
|
|
|
‡2
NTA|377242942
|
996
|
|
|
‡2
ISNI|0000000382209766
|
996
|
|
|
‡2
PLWABN|9810551735505606
|
996
|
|
|
‡2
LC|nr 99037748
|
996
|
|
|
‡2
DNB|1244550264
|
996
|
|
|
‡2
DNB|1326183923
|
996
|
|
|
‡2
ISNI|0000000393880168
|
996
|
|
|
‡2
NTA|321775775
|
996
|
|
|
‡2
BNF|17726069
|
996
|
|
|
‡2
RERO|A023710780
|
996
|
|
|
‡2
ISNI|000000001798983X
|
996
|
|
|
‡2
BNE|XX5340325
|
996
|
|
|
‡2
DNB|121249123
|
996
|
|
|
‡2
NUKAT|n 2019201253
|
996
|
|
|
‡2
J9U|987007389251005171
|
996
|
|
|
‡2
ISNI|0000000396943582
|
996
|
|
|
‡2
ISNI|0000000368704074
|
996
|
|
|
‡2
NTA|072613289
|
996
|
|
|
‡2
NTA|370138244
|
996
|
|
|
‡2
ISNI|000000039507985X
|
996
|
|
|
‡2
DNB|1324090367
|
996
|
|
|
‡2
ISNI|0000000108834091
|
996
|
|
|
‡2
NTA|296537551
|
996
|
|
|
‡2
ISNI|0000000434960915
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|